tiprankstipranks
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
PremiumThe FlyCantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
2M ago
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
2M ago
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
2M ago
Insmed Strikes $500M Deal with Leerink for Growth and R&D
PremiumCompany AnnouncementsInsmed Strikes $500M Deal with Leerink for Growth and R&D
2M ago
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
2M ago
Insmed reports Q4 EPS ($1.28), consensus ($1.15)
PremiumThe Fly
Insmed reports Q4 EPS ($1.28), consensus ($1.15)
2M ago
Insmed: Data from Phase 3 ASPEN study of Brensocatib due in latter part of 2Q
PremiumThe FlyInsmed: Data from Phase 3 ASPEN study of Brensocatib due in latter part of 2Q
4M ago
Insmed sees FY23  ARIKAYCE revenue $305.2M, consensus $302.75M
PremiumThe Fly
Insmed sees FY23 ARIKAYCE revenue $305.2M, consensus $302.75M
4M ago
Insmed initiated with an Overweight at Wells Fargo
PremiumThe Fly
Insmed initiated with an Overweight at Wells Fargo
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100